Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers ...Middle East

PR Newswire - News
Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers
PHOENIX, Nov. 4, 2020 /PRNewswire/ -- Amnio Technology, LLC, a global leader in the development and distribution of amniotic tissue allografts, is announcing today that it has received authorization from FDA to proceed with a Phase 2 clinical trial under an Investigational New Drug (IND)...

Read More Details
Finally We wish PressBee provided you with enough information of ( Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers )

Apple Storegoogle play

Also on site :